1. Repository of OAI
Ελληνικά   English  

Browsing by Author Papathanasiou, A. I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 13 of 13
TitleAuthor(s)Issue date???itemlist.???
Acute and long-term antiplatelet therapyPapathanasiou, A. I.; Goudevenos, J. A.; Mikhailidis, D. P.; Tselepis, A. D.24-Nov-2015-
The Antiplatelet and Antithrombotic Actions of StatinsMitsios, J. V.; Papathanasiou, A. I.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromesMitsios, J. V.; Papathanasiou, A. I.; Rodis, F. I.; Elisaf, M.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Clinical significance of the atorvastatin-clopidogrel drug-drug interaction - ResponseMitsios, J. V.; Papathanasiou, A. I.; Rodis, F. I.; Elisaf, M.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
An epidemiologic study of acute coronary syndromes in northwestern GreecePapathanasiou, A. I.; Pappas, K. D.; Korantzopoulos, P.; Leontaridis, J. P.; Vougiouklakis, T. G.; Kiriou, M.; Dimitroula, V.; Michalis, L. K.; Goudevenos, J. A.24-Nov-2015-
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesMitsios, J. V.; Papathanasiou, A. I.; Elisaf, M. S.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery diseaseLourida, E. S.; Papathanasiou, A. I.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A(2)Lourida, E. S.; Georgiadis, A. N.; Papavasiliou, E. C.; Papathanasiou, A. I.; Drosos, A. A.; Tselepis, A. D.24-Nov-2015-
Patients with early rheumatoid arthritis have elevated autoantibody titers against oxidized forms of LDLLourida, E. S.; Georgiadis, A.; Papathanasiou, A. I.; Voulgari, P.; Drosos, A.; Tselepis, A. D.24-Nov-2015-
Potential statin-clopidogrel interaction requires more study - ResponseMitsios, J. V.; Papathanasiou, A. I.; Rodis, F. I.; Elisaf, M.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Rare association of diffused coronary ectasia and anomalous origin of left circumflex coronary artery in a man with heterozygous familial hypercholesterolemia: a case reportPapathanasiou, A. I.; Katsouras, C. S.; Goudevenos, I. A.; Michalis, L. K.; Achenbach, K.; Sideris, D. A.24-Nov-2015-
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes - Role of the lipoprotein-associated phospholipase A(2) and the effect of atorvastatin treatmentPapathanasiou, A. I.; Lourida, E. S.; Tsironis, L. D.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentPapathanasiou, A. I.; Lourida, E. S.; Tsironis, L. D.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Showing results 1 to 13 of 13